Core Viewpoint - Cotton is evolving from a traditional textile material to a multifunctional resource, capable of producing valuable compounds like astaxanthin through advanced biotechnological methods [4][12]. Group 1: Cotton's Traditional Uses - Cotton fibers are categorized into three main types: coarse short-staple cotton, fine-staple cotton, and long-staple cotton, each serving different textile applications [4]. - The majority of cotton grown in China is fine-staple cotton, which is widely used in everyday textiles and medical supplies [4]. Group 2: Innovative Applications - The development of engineered cotton capable of producing astaxanthin, a potent natural antioxidant, represents a significant advancement in cotton's utility [6][12]. - Astaxanthin is recognized for its superior antioxidant properties compared to vitamin E and β-carotene, with applications in food, feed, pharmaceuticals, and cosmetics [6]. Group 3: By-products and Sustainability - Cotton seeds are a major source of edible oil and protein for animal feed, with cottonseed meal being the second-largest source of plant protein in China [8]. - Cotton by-products, such as cottonseed hulls and short fibers, have diverse applications in food, pharmaceuticals, and biodegradable materials, enhancing the overall value of cotton production [9][10]. Group 4: Future Prospects - The integration of synthetic biology in cotton research is expected to lead to the development of new cotton varieties with enhanced functionalities and colors, reducing environmental impact from dyeing processes [12]. - The ongoing research aims to expand cotton's application across agriculture, food, health products, energy, and environmental sectors, positioning cotton as a versatile and sustainable resource [11][12].

Core Viewpoint - The article discusses the construction project of a collagen production line by Shandong Furida Biotechnology Co., Ltd., highlighting its investment, production capacity, and timeline for completion [2]. Summary by Sections Project Progress - Shandong Furida Biotechnology Co., Ltd. is expanding its collagen production line, located in Linyi City, Shandong Province, with a total investment of 12 million yuan, including 500,000 yuan for environmental protection [2]. - The project will utilize existing facilities and is expected to produce 200 kg of collagen annually upon completion in June 2025 [2]. Existing Project Status - The company has several ongoing projects, including: - Sodium hyaluronate project with an annual output of 50 tons [4]. - Various fermentation projects with different production capacities, including: - Recombinant Type II collagen: 115.2 kg/a - Recombinant Type XVII collagen: 64 kg/a - Recombinant Type III transmembrane collagen: 20.8 kg/a - The total annual production capacity for collagen will reach 200 kg [3][4]. Industry Events - The fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang Province, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [8][9].

8月8日上午，2025年服务消费季活动——"一带一路"美食旅游产业交流大会暨昆明民族风情美食消费季启动 仪式在滇池国际会展中心举行。活动旨在进一步弘扬中华饮食文化，推动地方特色菜品的传承与创新，凝聚 美食产业发展力量，激发餐饮市场发展活力，促进民族美食文旅产业深度融合发展，持续扩大云南民族特色 餐饮在全国的知名度和影响力。 七彩美伊以"助力乡村振兴，打造石林撒尼刺绣"劳务品牌为重要抓手，培育彝族撒尼刺绣创业就业基地，带 动群众就近就业，从事缝纫、刺绣、编织、民族服饰技艺传承和生产，让贫困群众在家门口实现就业增收致 富。 "我们一贯奉行'产品质量就是企业的生命'的发展理念。公司实验室投资500多余万元，设有技术研发中心， 质量检测涵盖理化、微生物、及精密仪器检测等。"据介绍，云南云彩金可虾青素生物科技有限公司是一家 植物提取现代化食品加工型企业。公司依托在石林县台创园投资建设的云南雨生红球藻生产基地100%投资 建设，项目主要建设雨生红球藻干燥加工生产线、虾青素油乙醇提取生产线、二氧化碳超临界萃取生产线、 微藻技术研究及开发实验室、保健食品生产线等。 从鲜美的果蔬，到醇厚的茶叶，再到精致的手工艺品……乡愁四韵（ ...

Core Viewpoint - The establishment of a joint venture, Jindawei (Inner Mongolia) Nutritional Food Co., Ltd., between Jindawei Pharmaceutical and Aibede Life Science Research Institute aims to enhance product absorption efficiency and competitiveness in the global market [1] Group 1 - The joint venture is located in the industrial park of Tokto County, Hohhot City, Inner Mongolia [1] - The collaboration will leverage nanocrystal production technology for products such as Coenzyme Q10, Astaxanthin, Curcumin, and Quercetin [1] - The application of this technology is expected to significantly improve the absorption speed and efficiency of the company's related products [1]

Core Viewpoint - Astaxanthin, a highly effective antioxidant pigment, is gaining attention for its applications in food, cosmetics, and pharmaceuticals, with a recent study demonstrating a high-yield production system using Schizochytrium for both astaxanthin and DHA [1][3]. Group 1: Research Findings - The study reported an increase in astaxanthin content from 7.56 μg/g to 55.17 μg/g through electroporation-induced color screening [2]. - Further enhancement of astaxanthin content to 374.85 μg/g was achieved by overexpressing five key genes involved in the astaxanthin synthesis pathway [2]. - The final engineered strain produced astaxanthin at a yield of 29.53 mg/L (1.913 mg/g DCW) while maintaining DHA production at 3.83 g/L, constituting 45% of total lipid content [2]. Group 2: Implications for Industry - The reported astaxanthin yield represents the highest level achieved in Schizochytrium to date, laying a foundation for the commercial scalability of astaxanthin biosynthesis [3]. - The advancements in metabolic engineering and mutagenesis techniques highlight the potential for increased production efficiency in the biotechnology sector [1][3]. Group 3: Upcoming Events - The 4th Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, focusing on AI and bio-manufacturing, green chemistry, new materials, future food, and agriculture [6][8]. - The conference will feature various activities, including a youth forum, high-level discussions, and a closed-door seminar on AI-enabled innovations in bio-manufacturing [6][7].

Core Viewpoint - *ST Wanfang (000638) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, marking the second time the company has faced such scrutiny since July 2025 [1][2][9]. Financial Performance - The company has experienced a significant decline in gross profit margin, dropping from 29.24% in 2021 to 20.94% in 2022, and further plummeting to 3.15% in 2023, before a slight recovery to 5.59% in 2024 [4][5]. - For the first half of 2025, the company anticipates a net loss of between 4.5 million to 6.5 million yuan, indicating a shift from profit to loss year-on-year [4]. Business Structure and Revenue Sources - The company's revenue is heavily reliant on its agricultural processing and sales business, which contributed 323 million yuan in 2024, accounting for over 80% of total revenue. In contrast, the contributions from non-ferrous metals and military products were significantly lower at 35 million yuan and 22 million yuan, respectively [5][6]. - The agricultural processing business has a low gross profit margin of only 2.5% in 2024, while the military business, which has a gross margin close to 40%, represents a small portion of total revenue [6]. Regulatory Issues - The company has faced multiple disciplinary actions for failing to disclose accurate and complete performance forecasts, with the latest incident occurring in April 2025 when it revised its profit expectations downward significantly [10][11]. - The CSRC's investigation could lead to severe consequences, including the potential for mandatory delisting if major violations are confirmed [4].

Core Viewpoint - The SynBioCon 2025 conference will focus on the integration of AI with biomanufacturing, green chemicals and new materials, future food, and future agriculture, aiming to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan period [1]. Group 1: Conference Overview - The conference will take place from August 20 to 22, 2025, in Ningbo, Zhejiang [1]. - It aims to promote the transfer and transformation of scientific and technological achievements, product scaling, and talent acquisition in the biomanufacturing sector [1]. Group 2: Organizers and Supporters - Organized by Ningbo Detaizhongyan Information Technology Co., Ltd. (DT New Materials) and co-organized by several academic and research institutions [2]. - Supported by various associations and alliances, including the Chinese Society of Biotechnology and the Zhejiang Synthetic Biology Industry Technology Alliance [2]. Group 3: Expert Guests - Notable experts include Zhang Xian'en, Dean of the School of Synthetic Biology at Shenzhen University of Technology, and other prominent figures from various universities and research institutes [4][5][6][7][10][12][14][18][20][22][30][32]. Group 4: Conference Agenda - The agenda includes a series of forums and discussions on topics such as green chemicals, new materials, AI in biomanufacturing, and future food and agriculture [36][37]. - Specific sessions will focus on the construction of efficient cell factories for the production of aromatic compounds and the biomanufacturing of polyamide materials [8][11].

Group 1: Health Impacts of High Temperatures - Extreme heat poses significant health risks, including heatstroke and accelerated aging processes in humans [1] - High temperatures induce oxidative stress, disrupt protein homeostasis, activate inflammatory pathways, and directly age skin and organs [1][3] - Chronic inflammation triggered by high temperatures can silently damage various body tissues [3] Group 2: Antioxidant Properties of Astaxanthin - Astaxanthin, a potent antioxidant, can penetrate cell membranes and effectively neutralize free radicals throughout the body [3] - It inhibits the production and release of inflammatory factors such as IL-6 and TNF-α, providing a balanced anti-inflammatory effect [3][5] - Astaxanthin offers protective benefits against UV-induced skin damage, reducing the penetration and harm caused by UVA and UVB rays [5] Group 3: Industry Leadership and Product Development - Green A Bio is a leading player in the astaxanthin industry, having developed proprietary technologies that break the technological monopoly held by the US and Japan [7] - The company has launched innovative products, including the "Red A Aista" and the anti-aging astaxanthin series, which combine natural astaxanthin with GABA and collagen peptides [7] - The growing medical research on astaxanthin suggests expanding applications in anti-aging and disease prevention, positioning it as a key health supplement [7]

Core Viewpoint - The fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI with bio-manufacturing, green chemicals and new materials, future food, and future agriculture [1]. Group 1: Conference Overview - The conference aims to explore the development trends of the bio-manufacturing industry during the 14th Five-Year Plan, innovations driven by AI in bio-manufacturing, and the technologies and products that will sustain the vitality of the bio-manufacturing sector [1]. - The event will facilitate the transfer and transformation of scientific achievements, product scaling, and talent acquisition [1]. Group 2: Organizers and Support Units - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and co-organized by several institutions including Peking University Ningbo Institute of Ocean Medicine and Ningbo Enzyme Science Bioengineering Co., Ltd. [2]. - Supporting units include the Chinese Society of Biotechnology's Bio-based Materials Committee, Zhejiang Synthetic Biology Industry Technology Alliance, and Shanghai Future Industry Bio-Manufacturing Committee [2]. Group 3: Expert Speakers - Notable speakers include Zhang Xian'en, Dean of the Synthetic Biology Institute at Shenzhen University, who is recognized for his contributions to synthetic biology and bio-manufacturing [6][7]. - Other experts include professors from various universities who will share insights on topics such as the construction of efficient cell factories for aromatic compound production and the biomanufacturing of polyamide materials [10][15][28]. Group 4: Conference Agenda - The agenda includes a series of forums and discussions on topics such as green chemicals and new materials, AI in bio-manufacturing, and future food and agriculture [41]. - The first day features a macro forum on the bio-manufacturing industry, while subsequent days will include specialized forums and networking opportunities [41]. Group 5: Registration and Participation - Registration for the conference is open, and participants can sign up to engage in discussions and networking opportunities related to synthetic biology and bio-manufacturing [42][44].

Core Viewpoint - Zhejiang Kemin Biopharmaceutical Co., Ltd. is advancing its production capabilities by launching a project to produce 1,400 tons of bio-fermentation products annually, focusing on environmentally friendly alternatives to previously planned products [1][2]. Project Overview - Project Name: Annual production of 1,400 tons of bio-fermentation series products and supporting construction project [2] - Project Nature: Technological upgrade [2] - Construction Unit: Zhejiang Kemin Biopharmaceutical Co., Ltd. [2] - Location: Zhejiang Xinchang Economic Development Zone [2] - Scale: The project includes two adjacent closed production lines, one for fermentation processes and another for extraction processes, with advanced equipment to achieve a production capacity of 1,400 tons per year [2]. Product Details - The project will produce various bio-fermentation products, including: - Coenzyme Q10: 1,080 tons/year - Astaxanthin: 100 tons/year - Calcium Pantothenate: 1,090 tons/year - Beta-Carotene: 60 tons/year - Lycopene: 3 tons/year - PQQ: 7 tons/year - Dehydroacetic Acid: 60 tons/year [2]. Financial Performance - Zhejiang Pharmaceutical Co., Ltd. expects a net profit attributable to shareholders of 600 million to 720 million yuan for the first half of 2025, representing a year-on-year increase of 90.28% to 128.33% [2]. - The net profit excluding non-recurring gains and losses is projected to be between 590 million and 708 million yuan, reflecting an increase of 86.27% to 123.53% year-on-year [2]. Market Dynamics - The company is focusing on maintaining safety in production and product quality amidst intense market competition and a complex economic environment [3]. - The demand and sales prices for the company's main products in the life nutrition segment have increased compared to the same period last year, driving revenue growth [3]. Industry Event - The 4th Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [4][6].